Communicate with Supplier? Supplier
Kelly Ms. Kelly
What can I do for you?
Chat Now
Chat Now Contact Supplier

 Shandong Haohong Biotechnology Co., Ltd.

  • All
  • Title
  • All
  • Title
HomeProductsActive Pharmaceutical Ingredient(API)Regorafenib API

Regorafenib API (Total 1 Products)

Product categories of Regorafenib API, we are specialized manufacturers from China, Regorafenib; 755037-03-7; BAY 73-4506; Stivarga; 4-(4-(3-(4-Chloro-3-(Trifluoromethyl)Phenyl)Ureido)-3-Fluorophenoxy)-N-Methylpicolinamide; Regorafenibum;, Regorafenib API suppliers/factory, wholesale high-quality products of Regorafenib API R & D and manufacturing, we have the perfect after-sales service and technical support. Look forward to your cooperation!
Regorafenib CAS 755037-03-7 good quality


Packaging: PE BAG+Aluminum foil bag+FIBRE DRUM

Supply Ability: 30MT/MONTH

Product Name Regorafenib 4 4 3 4 Chloro 3 trifluoromethyl phenyl ureido 3 fluorophenoxy N methylpicolinamide 4 4 4 Chloro 3 trifluoromethyl phenyl carbamoyl amino 3 fluorophenoxy N methylpyridine 2 carboxamide Stivarga 4 4 4 chloro 3 trifluoromethyl...

China Regorafenib API Suppliers

Regorafenib is an orally bioavailable small molecule with potential antiangiogenic and antineoplastic activities. Regorafenib binds to and inhibits vascular endothelial growth factor receptors (VEGFRs) 2 and 3, and Ret, Kit, PDGFR and Raf kinases, which may result in the inhibition of tumor angiogenesis and tumor cell proliferation. VEGFRs are receptor tyrosine kinases that play important roles in tumor angiogenesis; the receptor tyrosine kinases RET, KIT, and PDGFR, and the serine/threonine-specific Raf kinase are involved in tumor cell signaling.

Regorafenib is an oral multi-kinase inhibitor that is used in the therapy of refractory metastatic colorectal cancer, hepatocellular carcinoma and gastrointestinal stromal tumor. Regorafenib has been associated with frequent serum aminotransferase elevations during therapy and with rare, but sometimes severe and even fatal instances of clinically apparent liver injury.




About Us